MABWELL-B
0249318AListed醫療健康 · 迈威生物是一家专注于创新生物药研发的生物科技公司，核心产品为9MW2821。
High attention
75.5
/100
- Offer price
- HK$27.64
- Final offer price
- HK$27.64
- Lot / entry fee
- 200 shares · HK$6K
- Proceeds
- HK$1.30B
- Sponsor
- CITIC Securities / Haitong International
- Est. margin oversub.
- 302.9x
- Public oversub.
- 481.7x
- One-lot win rate
- 1.0%
- First-day return
- +0.6%
Offer starts
Apr 20
Offer closes
Apr 23
Grey market
Apr 27
Listing
Apr 28
AI reference scoring and scenarios
After grey market
After grey market L1 heat score
75.5/ 100
Data coverage High
Target
Historical calibration
Listing-day trend
PositivePartial basis
Up probability
95.0%
First-day reference range
-8.0% – +29.0%
Published outcome check
First-day resultFlat+0.6%
Our call: Trend call valid
Covered 17/25 core factors
UsedMissingNot yet scorableN/A
Margin oversubscription
High heatOffer size
Weaker qualityCornerstone lockup
—Post-lockup offer value
—Recent same-rule trend
Strong trendRecent same-type trend
Strong trendRecent sector trend
Strong trendValuation
Weak appealFundamental quality
Average qualityGrowth quality
High qualityProfitability
Weak qualityCash runway
High qualityCustomer concentration
—Cornerstone quality
Strong supportSponsor record
Strong recordGreenshoe arrangementNo greenshoe
Stabilizer track record
—A-share pre-grey trend
—A-share listing-day trend
—Public oversubscription
High heatOne-lot win rate
High heatInternational placing
High heatFinal pricing position
—Actual greenshoe use
—Grey market return
Neutral trendThe assessment and probability ranges are informational only and are not investment advice.
AI Research Report
After grey marketThe analysis report for this IPO is being generated.